Logo image
Prof. Dr. med. Salvatore Grisanti working place, University Hospital Schleswig-Holstein Lubeck
Prof. Dr. med. Salvatore Grisanti
Excellent
AiroScore
9.70

Prof. Dr. med. Salvatore Grisanti

ophthalmology and eye cancer
ophthalmology and eye cancer
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
96%32 years9.7/10$$$456No

Overview

Country, City
Germany, Lubeck
Health facility
University Hospital Schleswig-Holstein Lubeck
Medical unit
Department of ophtalmology

About the doctor

Prof. Dr. med. Salvatore Grisanti is an experienced ophthalmologist specializing in eye cancer. With 31 years of experience, he has an impressive CV, including extensive training and certifications in oncology and ophthalmology. He works at the Department of Ophthalmology at the University Hospital Schleswig-Holstein in Lubeck, Germany. Throughout his career, Dr. Grisanti has held various roles, ranging from senior physician to director of ophthalmology departments. He has managed cancer patients in different healthcare settings and has been involved in producing protocols for chemotherapy treatments. Additionally, he has published 456 scientific publications, showcasing his expertise and dedication to advancing research in his field. Dr. Grisanti's unique contributions include his involvement in clinical trials, the interpretation of trial data, and the design and implementation of ancillary translational studies. He has also been a member of international study groups, participated in workshops, and collaborated with key opinion leaders in the field of oncology. Overall, Dr. Salvatore Grisanti's extensive experience, specialization in ophthalmology and eye cancer, and contributions to research and clinical practice make him a highly skilled and sought-after medical professional in his field.

Skills & Expertise

cancer
carcinoma
macular degeneration
melanoma
agerelated macular degeneration
metastatic
surgery
glaucoma
bevacizumab
retina
uveal melanoma
retinal pigment
oncology
photodynamic therapy
tumor
optical coherence tomography
eye
vitreoretinopathy
proliferative vitreoretinopathy
head
verteporfin photodynamic therapy
vertebrate retina
epithelial cells
retinal function
infection
lymphoma
choroidal neovascularization
neovascular membranes
pigment epithelial cells
choroidal neovascular membranes
stereotactic radiotherapy
chemotherapy
melanoma cells
immunotherapy
circulating melanoma
malignant
ophthalmology
vascular endothelial growth
openangle glaucoma
retinal pigment epithelium
rhegmatogenous retinal detachment
choroidal perfusion
eye cancer
carcinoma cell
eyelid
atrophy
orbital tumors
retinal choroidal perfusion
uveitis
eyedrops

Resume

CV (Curriculum Vitae)

Education
  • 1992 Studied human medicine at the University of Palermo
  • 1992 Obtaining a license for medical practice
  • 1997 Defense of the dissertation in immuno-pharmacology at the University of Palermo
  • 2001 Trained for palliative and cancer pain treatments up to terminal sedation
  • Obtaining specialization in ophthalmology
  • Habilitation and a teaching license
  • 2001 Board certification in oncology from the University of Milan, National Cancer Institute of Milan
  • 2011 Received qualifications in the field of oncology from the European Society of Medical Oncology
  • Trained at Johnson & Johnson for the use of the CellSearch System (Veridex) for circulating tumor cells identification and enumeration and continuous certification of cell interpretation assessment
  • Certification of basic life support + defibrillator provider
  • Certification of advanced life support provider
  • Certification of knowledge of good clinical practice guidelines
  • Good knowledge of the statistical package for the social sciences software package for biomedical statistics
  • Proficiency in conducting statistical analyzes in biomedicine and meta-analyses
Experience
  • 2001 Senior Physician in adult oncology of the Department of medical oncology at the Civil Hospitals and University of Brescia
  • 2001 Clinical management of cancer patients in centers ranging from academic hospitals, cancer institutes, and large general hospitals to small day hospitals, thus, recapitulating all the spectrum of cancer patients both as in and outpatients
  • 2001-2002 Medical Assistant in hematology and oncology with coordinator responsibilities of the bone marrow transplantation unit at the Oncology Institute of Southern Switzerland of Bellinzona
  • 2008 Director of the Department of ophtalmology at the University Hospital Schleswig-Holstein Lubeck (UKSH)
  • 2013 Head of the Continuous Medical Education (CME) Program of the Department of Oncology at the Civil Hospitals of Brescia
  • 2013 Senior Instructor for medical students and junior physicians in oncology residency
  • 2018 Associate Professor of medical oncology within the Italian University system
Awards & Memberships
  • 2001 Production of currently used protocols of chemotherapy for the medical oncology unit online system in collaboration with the pharmacy and antiblastic drugs unit
  • 2001 Experience in trial data interpretation, statistical analysis, and scientific reports writing up to manuscript submission to scientific journals
  • 2001 Collaboration in writing projects for national and international grants application
  • 2001 Writing of synopses/clinical protocols of phase I-III clinical trials, statistical design of the study, design, and implementation of ancillary translational studies in collaboration with the internal Data Management Center submission to ethical committee board and relationships with external centers
  • 2001-2002 Member of the Scientific Secretary Office of the international extranodal lymphoma study group
  • 2001-2002 Organization of internal workshops on scientific breakthroughs from pertinent scientific literature or meetings
  • 2001-2002 Writing and production of the protocol of the Phase III randomized clinical trial IELSG#19: “Multicenter randomized trial of chlorambucil versus chlorambucil plus rituximab versus rituximab alone in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)”
  • 2001-2002 Participation in the American Society of Clinical Oncology-American Association for Cancer Research-Federation of European Cancer Societies workshop: “Flims methods in clinical cancer research”
  • 2001-2002 Relationships with key opinion leaders and organization responsibilities of the European Society for Medical Oncology conference
  • 2001-2002 Member of the scientific secretary office of the International extranodal lymphoma study group
  • 2013 Clinical Member of the ethical committee board of Neurological Institute “Carlo Besta” and Institute of Pharmacological Research of Mario Negri
  • 2013 Supervisor for management of special medical problems and reporting to the internal pharmacovigilance unit
  • 2013 Principal investigator of several academy-sponsored retrospective and prospective clinical trials
  • 2013 Oral presentations, posters, abstracts, and new proposals at international meetings
  • 2016 Core Faculty Member of the European School of Oncology
  • 2018 Core Member of phase I studies team of the Department of Oncology at the Civil Hospitals of Brescia
  • Listed in the FOCUS doctor top lists are diabetic eye diseases, corneal and retinal diseases

Languages

English flag
English
German flag
German

Publications

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

September, 2023

Axial Improvement after Casirivimab/Imdevimab Treatment for COVID-19 in Parkinson's Disease.

September, 2023

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.

21 August, 2023

Location

Ratzeburger Allee, 160, 23562 Lubeck, Germany

FAQ

What is the specialization of Prof. Dr. med. Salvatore Grisanti?

The primary specialization of the doctor is ophthalmology and eye cancer .

What is the experience of the specialist?

Prof. Dr. med. Salvatore Grisanti has been practicing for more than 32 years.

What is the rating of the doctor?

What topics does Prof. Dr. med. Salvatore Grisanti expert at?

The doctor has excellent knowledge in cancer, carcinoma, macular degeneration, melanoma, agerelated macular degeneration.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. med. Salvatore Grisanti doesn’t perform virtual appointments.

Prof. Dr. med. Salvatore Grisanti
Prof. Dr. med. Salvatore Grisanti

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Salvatore Grisanti